Asia Pacific Bone Grafts & Substitutes Market To Reach $1.06 Billion By 2030

Asia Pacific Bone Grafts & Substitutes Market Growth & Trends 

The Asia Pacific bone grafts & substitutes market size is estimated to reach USD 1.06 billion by 2030, expanding at a CAGR of 8.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing the incidence of bone disorders due to road accidents and sports injuries is driving the market. Increasing demand for the development of biocompatible bone grafts in order to reduce adverse reaction is driving demand for synthetic grafts.

The industry players are continuously trying to develop new products with better biocompatibility, bioactivity, and suitable mechanical properties. For instance, in June 2019, Biogennix received 510(K) clearance from USFDA for Agilon, which is fully biocompatible with human bone. In August 2019, NanoFUSE biologics marked its presence in Thailand with FDA approved NanoFUSE biologics, a bioactive glass with a demineralized bone matrix.

 Request a free sample copy or view report summary: Asia Pacific Bone Grafts & Substitutes Market Report

Asia Pacific Bone Grafts & Substitutes Market Report Highlights

• In terms of revenue, the allograft segment dominated the market with a revenue share of 57.6% in 2024. The growth can be attributed to its increased usage in medical procedures and product innovation.

• The Demineralized Bone Matrix (DBM) segment dominated the allografts segment as of 2024 owing to its increased commercial accessibility in a number of standard forms and sources.

• On the basis of application, the spinal fusion segment held the largest revenue share in 2024 owing to the growing number of spinal fusion procedures and new product approvals for the same.

• The dental segment is expected to show lucrative growth over the forecast period. The growth can be attributed to the increasing number of dental implant surgeries and product availability.

• An increasing number of government initiatives and medical tourism is expected to propel market growth. Moreover, the growing number of bone and joint disorders due to the increasing aging population is further increasing the growth.

Asia Pacific Bone Grafts & Substitutes Market Segmentation

Grand View Research has segmented the Asia Pacific bone grafts & substitutes market based on material type, application, and country:

Asia Pacific Bone Grafts & Substitutes Material Type Outlook (Revenue, USD Million, 2018 - 2030)

• Allograft

  • Demineralized Bone Matrix

  • Others

• Synthetic

  • Ceramics

    • HAP

    • ß-TCP

    • α-TCP

    • bi-phasic calcium phosphates (BCP)

    • Others

  • Composites

  • Polymers

  • Bone Morphogenic Proteins (BMP)

Asia Pacific Bone Grafts & Substitutes Application Outlook (Revenue, USD Million, 2018 - 2030)

• Craniomaxillofacial

• Dental

• Foot and Ankle

• Joint Reconstruction

• Long Bone

• Spinal Fusion

Asia Pacific Bone Grafts & Substitutes Country Outlook (Revenue, USD Million, 2018 - 2030)

• China

• Japan

• India

• South Korea

• Australia

• Thailand 

List of Key Players of Asia Pacific Bone Grafts & Substitutes Market

• Baxter.

• Medical Device Business Services, Inc.

• NuVasive, Inc.

• Stryker

• Medtronic

• Zimmer Biomet.

• Smith+Nephew.

• Orthofix Medical Inc.

• Wright Medical Group N.V.

• Geistlich Pharma AG